VIE - Viela Bio Inc. (VIE) CEO Bing Yao on Q3 2020 Results - Earnings Call Transcript
Viela Bio, Inc. (VIE) Q3 2020 Earnings Conference Call November 10, 2020, 05:00 PM ET Company Participants Mitchell Chan - CFO Bing Yao - Chairman and CEO Jörn Drappa - Chief Medical Officer and Head R&D Bill Ragatz - SVP, Head Commercial Conference Call Participants Seamus Fernandez - Guggenheim Jeff Hung - Morgan Stanley Paul Choi - Goldman Sachs Joseph Thome - Cowen & Company Kenneth Shields - Wedbush Securities Derek Archila - Stifel Raghuram Selvaraju - H.C. Wainwright Yatin Suneja - Guggenheim Presentation Operator Good afternoon ladies and gentlemen, and welcome to the Viela Bio Third Quarter 2020 Earnings Conference Call. At this time, all participants are in listen-only mode. Later we will conduct a question-and-answer session and instructions will be given at that time. As a reminder, this conference call is being recorded. I would now like to hand the call over to Mr. Mitchell Chan, Chief Financial
For further details see:
Viela Bio, Inc. (VIE) CEO Bing Yao on Q3 2020 Results - Earnings Call Transcript